PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 10, Pages 3134
Publisher
MDPI AG
Online
2020-09-28
DOI
10.3390/jcm9103134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis C virus regulates proprotein convertase subtilisin/kexin type 9 promoter activity
- (2018) Zhubing Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Proprotein convertase subtilisin/kexin type 9 inhibits hepatitis C virus replication through interacting with NS5A
- (2018) Zhubing Li et al. JOURNAL OF GENERAL VIROLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Geranylgeraniol prevents the simvastatin-induced PCSK9 expression: Role of the small G protein Rac1
- (2017) Nicola Ferri et al. PHARMACOLOGICAL RESEARCH
- Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study
- (2017) Massimiliano Ruscica et al. Journal of the American Heart Association
- Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9
- (2017) Anastasia Hyrina et al. EBioMedicine
- Liver fat accumulation is associated with circulating PCSK9
- (2016) Massimiliano Ruscica et al. ANNALS OF MEDICINE
- Statins can exert dual, concentration dependent effects on HCV entry in vitro
- (2016) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer
- (2016) A. Blythe Ryerson et al. CANCER
- Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin
- (2016) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism: experimental animal models and clinical evidence
- (2016) Nicola Ferri et al. Translational Research
- Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes
- (2016) Aarti Ramanathan et al. PLoS One
- Decreased PCSK9 expression in human hepatocellular carcinoma
- (2015) Mamatha Bhat et al. BMC GASTROENTEROLOGY
- Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
- (2015) Zobair M. Younossi et al. HEPATOLOGY
- Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line
- (2015) Massimiliano Ruscica et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
- (2015) Yao-Hsu Yang et al. JOURNAL OF HEPATOLOGY
- Reduction of circulating PCSK9 and LDL-C levels by liver-specific knockdown of HNF1α in normolipidemic mice
- (2015) Vikram Ravindra Shende et al. JOURNAL OF LIPID RESEARCH
- Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
- (2013) Yu-Tse Tsan et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatitis C Virus Stimulates Low-Density Lipoprotein Receptor Expression To Facilitate Viral Propagation
- (2013) G. H. Syed et al. JOURNAL OF VIROLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- PCSK9 impedes hepatitis C virus infectionin vitroand modulates liver CD81 expression
- (2009) Patrick Labonté et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search